USAR

USA Rare EarthB

Nasdaq / Materials

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

20%

Probability

Target price

$39.60

Analysis reference price unavailable

Analysis 2026-01-24 · RankAlpha Sentiment AI

Most likely

Base case

55%

Probability

Target price

$23.50

Analysis reference price unavailable

Analysis 2026-01-24 · RankAlpha Sentiment AI

B-

Bear case

25%

Probability

Target price

$14.90

Analysis reference price unavailable

Analysis 2026-01-24 · RankAlpha Sentiment AI

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-01-24

AI commentary

Investor tone is mixed: filings and IR releases show active progress on pilot engineering and offtake talks but emphasize financing needs and schedule risk [#10Q-2025-07-09][#10K-2025-09-29]. Recent definitive offtake disclosures improved commercial credibility but have yet to translate into material revenue [#8-K-2025-11-18]. Overall market signals imply cautious optimism tied to execution milestones.

RankAlpha Sentiment AI - 2026-01-24

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-03-15eventInvestor presentation & site visitMedium impact

Company-listed event: investor presentation and site visit scheduled 2026-03-15; material technical/operational disclosures could move sentiment and short-term flows [#IR-Events-2026-03-15].

2026-09-30catalystPlanned capital raise / financing (H2 2026)High impact

MD&A flags cash runway into mid‑2026 and plans for a capital raise in H2 2026; a dilutive financing or failure to secure economics would be a near‑term negative risk to equity value [#10Q-2025-07-09].

2026-09-30catalystPilot plant commissioning (pilot completion / first runs)High impact

Pilot engineering contract executed 2025-06-15 and MD&A disclosure target commissioning Q3 2026; commissioning success would materially de‑risk scale-up and enable commercial trial runs [#10Q-2025-07-09][#IR-2025-06-15].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-01-24 • Updated nightlySource: Internal modelMethodology